These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 12709015)

  • 1. Targeting dendritic cells with CD44 monoclonal antibodies selectively inhibits the proliferation of naive CD4+ T-helper cells by induction of FAS-independent T-cell apoptosis.
    Termeer C; Averbeck M; Hara H; Eibel H; Herrlich P; Sleeman J; Simon JC
    Immunology; 2003 May; 109(1):32-40. PubMed ID: 12709015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of CD4+ T cell apoptosis as a consequence of impaired cytoskeletal rearrangement in UVB-irradiated dendritic cells.
    Wachter T; Averbeck M; Hara H; Tesmann JP; Simon JC; Termeer CC; Denfeld RW
    J Immunol; 2003 Jul; 171(2):776-82. PubMed ID: 12847245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A subclass of dendritic cells kills CD4 T cells via Fas/Fas-ligand-induced apoptosis.
    Süss G; Shortman K
    J Exp Med; 1996 Apr; 183(4):1789-96. PubMed ID: 8666935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T cell receptor ligation triggers novel nonapoptotic cell death pathways that are Fas-independent or Fas-dependent.
    Davidson WF; Haudenschild C; Kwon J; Williams MS
    J Immunol; 2002 Dec; 169(11):6218-30. PubMed ID: 12444127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elimination of activated but not resting primary human CD4+ and CD8+ T cells by Fas ligand (FasL/CD95L)-expressing Killer-dendritic cells.
    Hoves S; Krause SW; Herfarth H; Halbritter D; Zhang HG; Mountz JD; Schölmerich J; Fleck M
    Immunobiology; 2004; 208(5):463-75. PubMed ID: 15124861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A subclass of dendritic cells regulates the response of naive CD8 T cells by limiting their IL-2 production.
    Kronin V; Winkel K; Süss G; Kelso A; Heath W; Kirberg J; von Boehmer H; Shortman K
    J Immunol; 1996 Nov; 157(9):3819-27. PubMed ID: 8892611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dendritic cells genetically engineered to express Fas ligand induce donor-specific hyporesponsiveness and prolong allograft survival.
    Min WP; Gorczynski R; Huang XY; Kushida M; Kim P; Obataki M; Lei J; Suri RM; Cattral MS
    J Immunol; 2000 Jan; 164(1):161-7. PubMed ID: 10605007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD4 T lymphocytes are primed to express Fas ligand by CD4 cross-linking and to contribute to CD8 T-cell apoptosis via Fas/FasL death signaling pathway.
    Tateyama M; Oyaizu N; McCloskey TW; Than S; Pahwa S
    Blood; 2000 Jul; 96(1):195-202. PubMed ID: 10891451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dendritic cells recruit T cell exosomes via exosomal LFA-1 leading to inhibition of CD8+ CTL responses through downregulation of peptide/MHC class I and Fas ligand-mediated cytotoxicity.
    Xie Y; Zhang H; Li W; Deng Y; Munegowda MA; Chibbar R; Qureshi M; Xiang J
    J Immunol; 2010 Nov; 185(9):5268-78. PubMed ID: 20881190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitumour activity mediated by CD4+ cytotoxic T lymphocytes against MHC class II-negative mouse hepatocellular carcinoma induced by dendritic cell vaccine and interleukin-12.
    Homma S; Komita H; Sagawa Y; Ohno T; Toda G
    Immunology; 2005 Aug; 115(4):451-61. PubMed ID: 16011514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dendritic cells undergo rapid apoptosis in vitro during antigen-specific interaction with CD4+ T cells.
    Matsue H; Edelbaum D; Hartmann AC; Morita A; Bergstresser PR; Yagita H; Okumura K; Takashima A
    J Immunol; 1999 May; 162(9):5287-98. PubMed ID: 10228004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Self-veto mechanism of CD8+ cytotoxic effector T cells. Peptide-induced paralysis affects the peptide-MHC-recognizing cytotoxic T lymphocytes and is independent of Fas/Fas ligand interactions.
    Bergenthal A; Hofmann M; Heeg K
    Eur J Immunol; 1998 Jun; 28(6):1911-22. PubMed ID: 9645373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fas Ligand-dependent and -independent mechanisms of toxicity induced by T cell lymphomas in lymphoid organs and in the liver.
    Lombard C; McKallip RJ; Hylemon PB; Nagarkatti PS; Nagarkatti M
    Clin Immunol; 2003 Nov; 109(2):144-53. PubMed ID: 14597213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of CD44 in activation-induced cell death: CD44-deficient mice exhibit enhanced T cell response to conventional and superantigens.
    McKallip RJ; Do Y; Fisher MT; Robertson JL; Nagarkatti PS; Nagarkatti M
    Int Immunol; 2002 Sep; 14(9):1015-26. PubMed ID: 12202399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Killing of naive T cells by CD95L-transfected dendritic cells (DC): in vivo study using killer DC-DC hybrids and CD4(+) T cells from DO11.10 mice.
    Kusuhara M; Matsue K; Edelbaum D; Loftus J; Takashima A; Matsue H
    Eur J Immunol; 2002 Apr; 32(4):1035-43. PubMed ID: 11920570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mature but not immature Fas ligand (CD95L)-transduced human monocyte-derived dendritic cells are protected from Fas-mediated apoptosis and can be used as killer APC.
    Hoves S; Krause SW; Halbritter D; Zhang HG; Mountz JD; Schölmerich J; Fleck M
    J Immunol; 2003 Jun; 170(11):5406-13. PubMed ID: 12759415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of death receptor pathway in estradiol-induced T-cell apoptosis in vivo.
    Do Y; Ryu S; Nagarkatti M; Nagarkatti PS
    Toxicol Sci; 2002 Nov; 70(1):63-72. PubMed ID: 12388836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-idiotype antibody induced cellular immunity in mice transgenic for human carcinoembryonic antigen.
    Saha A; Chatterjee SK; Foon KA; Bhattacharya-Chatterjee M
    Immunology; 2006 Aug; 118(4):483-96. PubMed ID: 16895556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dendritic cells are resistant to apoptosis through the Fas (CD95/APO-1) pathway.
    Ashany D; Savir A; Bhardwaj N; Elkon KB
    J Immunol; 1999 Nov; 163(10):5303-11. PubMed ID: 10553053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fas ligand (CD95L) and B7 expression on dendritic cells provide counter-regulatory signals for T cell survival and proliferation.
    Lu L; Qian S; Hershberger PA; Rudert WA; Lynch DH; Thomson AW
    J Immunol; 1997 Jun; 158(12):5676-84. PubMed ID: 9190916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.